Marvin Slosman
Director · BioCardia, Inc.
IndividualBuying only
- 2025
- Jul 8, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Marvin Slosman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shane Thomas Gleason - $289K in NSPR purchases and sales in the last 12 months
- Paul Stuka - $284K in NSPR purchases and sales in the last 12 months
- Gary S. Roubin - $106K in NSPR purchases and sales in the last 12 months
- Simon H. Stertzer - $104K in BCDA purchases and sales in the last 12 months
- Scott R. Ward - $103K in NSPR purchases and sales in the last 12 months
- Peter Altman - $59K in BCDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Marvin Slosman?
Marvin Slosman is a corporate insider, tracked as Director of BioCardia, Inc. (BCDA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Marvin Slosman last file a Form 4?
The most recent primary Form 4 on record is dated 8 July 2026, one of 4 filings going back to 2025.
Has Marvin Slosman been buying or selling stock?
Recorded transactions: 2 open-market purchases ($50K) and 0 open-market sales across all tracked filings.
